Lifecell Corp - Current report filing (8-K)
April 24 2008 - 8:37AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): April 24, 2008
LIFECELL
CORPORATION
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
01-19890
|
76-0172936
|
(State
Or Other Jurisdiction Of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
One Millenium Way
Branchburg, New
Jersey
|
08876
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code (908)
947-1100
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02. Results of Operations and Financial Condition.
On April
24, 2008, LifeCell Corporation (the “Registrant”) issued a press release
regarding financial results for the first quarter ended March 31,
2008. A copy of this press release is being furnished as Exhibit 99.1
to this Current Report on Form 8-K.
The
information in this report under Item 2.02 is being furnished pursuant to Item
2.02 of Form 8-K, insofar as it discloses historical information regarding the
Registrant’s results of operations and financial condition as of, and for the
first quarter ended March 31, 2008. In accordance with General
Instructions B.2. of Form 8-K, the information in this Current Report on Form
8-K under Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for the
purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liability of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such a
filing.
Forward Looking
Statements
This
Current Report on Form 8-K, including Exhibit 99.1, contains forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, such as the Registrant’s expected financial
performance for 2008. Forward-looking statements typically are
identified by use of terms such as “may,” “will,” “should,” “plan,” “expect,”
“anticipate,” “estimate” and similar words, although some forward-looking
statements are expressed differently. Forward-looking statements
represent our management’s judgment regarding future events. Although
the Registrant believes that the expectations reflected in such forward-looking
statements are reasonable, the Registrant can give no assurance that such
expectations will prove to be correct. All statements other than
statements of historical fact included in this Current Report on Form 8-K
regarding the Registrant’s preliminary financial position, financial guidance,
business strategy, products, products under development and clinical trials,
markets, budgets, plans, regulatory matters or objectives for future operations
are forward-looking statements. The Registrant cannot guarantee the
accuracy of the forward-looking statements, and you should be aware that the
Registrant’s actual results could differ materially from those contained in the
forward-looking statements due to a number of factors, including the statements
under “Risk Factors” contained in the Registrant’s Annual Report on Form 10-K
for the fiscal year ended December 31, 2007 and other reports filed with the
Securities and Exchange Commission.
Item
9.01. Financial Statements and Exhibits.
As
described above, the following Exhibit is furnished as part of this Current
Report on Form 8-K:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
LIFECELL
CORPORATION
|
|
|
|
|
|
|
|
By:
|
/s/ Steven T. Sobieski
|
|
|
Steven
T. Sobieski
|
|
|
Chief
Financial Officer
|
Date: April
24, 2008
Lifecell Corp (MM) (NASDAQ:LIFC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lifecell Corp (MM) (NASDAQ:LIFC)
Historical Stock Chart
From Sep 2023 to Sep 2024